Finance

Beta
Lists
002826:SHE
Tibet Aim Pharm Inc
CN¥16.41
+0.24%
(+0.040) 1D
Jun 5, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002826...
Open
CN¥16.37
High
CN¥16.68
Low
CN¥16.22
Mkt. cap
3.12B
Avg. vol.
5.47M
Volume
3.73M
Dividend
0.91%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 24, 2025
P/E ratio
32.35
52-wk high
CN¥26.83
52-wk low
CN¥14.74
EPS
CN¥0.51
Shares outstanding
190.68M
No. of employees
405
Open
CN¥16.37
High
CN¥16.68
Low
CN¥16.22
Mkt. cap
3.12B
Avg. vol.
5.47M
Volume
3.73M
Dividend
0.91%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 24, 2025
P/E ratio
32.35
52-wk high
CN¥26.83
52-wk low
CN¥14.74
EPS
CN¥0.51
Shares outstanding
190.68M
No. of employees
405
News stories
From sources across the web
About Tibet Aim Pharm Inc
CEO-
Employees405
Founded2003
Headquarters-
SectorPharmaceutical industry
Websiteemyy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
162.91M
177.54M
147.29M
182.58M
Cost of goods sold
29.62M
27.76M
26.53M
31.99M
Cost of revenue
29.62M
27.76M
26.53M
31.99M
Research and development expenses
1.04M
7.64M
4.79M
599.92K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.71M
120.14M
104.13M
122.41M
Operating expense
110.10M
96.19M
143.90M
126.22M
Total operating expenses
139.72M
123.95M
170.43M
158.21M
Operating income
23.19M
53.59M
-23.14M
24.37M
Other non operating income
-6.23K
-13.92K
821.38K
228.21K
EBT including unusual items
28.16M
53.05M
11.45M
24.91M
EBT excluding unusual items
24.51M
53.97M
-21.21M
24.97M
Income tax expense
9.35M
9.03M
91.36K
5.26M
Effective tax rate
33.20%
17.02%
0.80%
21.12%
Other operating expenses
2.94M
-31.68M
36.59M
2.79M
Net income
18.76M
44.21M
10.82M
19.65M
Net profit margin
11.52%
24.90%
7.34%
10.76%
Earnings per share
-
-
-
-
Interest and investment income
1.65M
704.13K
1.26M
402.27K
Interest expense
-330.58K
-310.24K
-158.84K
-27.52K
Net interest expenses
1.32M
393.89K
1.10M
374.75K
Depreciation and amortization charges
-
-
-
-
EBITDA
28.22M
58.98M
-18.39M
29.12M
Gain or loss from assets sale
231.28K
-231.28K
231.32K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer